137 related articles for article (PubMed ID: 20205419)
21. Cellular internalization kinetics of (luciferin-)cell-penetrating peptide conjugates.
Eiríksdóttir E; Mäger I; Lehto T; El Andaloussi S; Langel U
Bioconjug Chem; 2010 Sep; 21(9):1662-72. PubMed ID: 20684543
[TBL] [Abstract][Full Text] [Related]
22. Translocation or membrane disintegration? Implication of peptide-membrane interactions in pep-1 activity.
Henriques ST; Castanho MA
J Pept Sci; 2008 Apr; 14(4):482-7. PubMed ID: 18181239
[TBL] [Abstract][Full Text] [Related]
23. Arginine-rich peptides and their internalization mechanisms.
Futaki S; Nakase I; Tadokoro A; Takeuchi T; Jones AT
Biochem Soc Trans; 2007 Aug; 35(Pt 4):784-7. PubMed ID: 17635148
[TBL] [Abstract][Full Text] [Related]
24. The cell penetrating peptides pVEC and W2-pVEC induce transformation of gel phase domains in phospholipid bilayers without affecting their integrity.
Herbig ME; Assi F; Textor M; Merkle HP
Biochemistry; 2006 Mar; 45(11):3598-609. PubMed ID: 16533042
[TBL] [Abstract][Full Text] [Related]
25. Studying the uptake of cell-penetrating peptides.
Holm T; Johansson H; Lundberg P; Pooga M; Lindgren M; Langel U
Nat Protoc; 2006; 1(2):1001-5. PubMed ID: 17406337
[TBL] [Abstract][Full Text] [Related]
26. Temperature-, concentration- and cholesterol-dependent translocation of L- and D-octa-arginine across the plasma and nuclear membrane of CD34+ leukaemia cells.
Fretz MM; Penning NA; Al-Taei S; Futaki S; Takeuchi T; Nakase I; Storm G; Jones AT
Biochem J; 2007 Apr; 403(2):335-42. PubMed ID: 17217340
[TBL] [Abstract][Full Text] [Related]
27. Distinct uptake routes of cell-penetrating peptide conjugates.
Lundin P; Johansson H; Guterstam P; Holm T; Hansen M; Langel U; EL Andaloussi S
Bioconjug Chem; 2008 Dec; 19(12):2535-42. PubMed ID: 19012426
[TBL] [Abstract][Full Text] [Related]
28. Studies on the cellular uptake of substance P and lysine-rich, KLA-derived model peptides.
Oehlke J; Lorenz D; Wiesner B; Bienert M
J Mol Recognit; 2005; 18(1):50-9. PubMed ID: 15386618
[TBL] [Abstract][Full Text] [Related]
29. The interaction of cell-penetrating peptides with lipid model systems and subsequent lipid reorganization: thermodynamic and structural characterization.
Alves ID; Correia I; Jiao CY; Sachon E; Sagan S; Lavielle S; Tollin G; Chassaing G
J Pept Sci; 2009 Mar; 15(3):200-9. PubMed ID: 18985709
[TBL] [Abstract][Full Text] [Related]
30. A comprehensive model for the cellular uptake of cationic cell-penetrating peptides.
Duchardt F; Fotin-Mleczek M; Schwarz H; Fischer R; Brock R
Traffic; 2007 Jul; 8(7):848-66. PubMed ID: 17587406
[TBL] [Abstract][Full Text] [Related]
31. Cationic cell-penetrating peptides interfere with TNF signalling by induction of TNF receptor internalization.
Fotin-Mleczek M; Welte S; Mader O; Duchardt F; Fischer R; Hufnagel H; Scheurich P; Brock R
J Cell Sci; 2005 Aug; 118(Pt 15):3339-51. PubMed ID: 16079278
[TBL] [Abstract][Full Text] [Related]
32. Self-assembly of peptides into spherical nanoparticles for delivery of hydrophilic moieties to the cytosol.
Collins L; Parker AL; Gehman JD; Eckley L; Perugini MA; Separovic F; Fabre JW
ACS Nano; 2010 May; 4(5):2856-64. PubMed ID: 20408581
[TBL] [Abstract][Full Text] [Related]
33. Comparison of the efficiency of complexes based on S4(13)-PV cell-penetrating peptides in plasmid DNA and siRNA delivery.
Cardoso AM; Trabulo S; Cardoso AL; Maia S; Gomes P; Jurado AS; Pedroso de Lima MC
Mol Pharm; 2013 Jul; 10(7):2653-66. PubMed ID: 23697649
[TBL] [Abstract][Full Text] [Related]
34. Induction of splice correction by cell-penetrating peptide nucleic acids.
El-Andaloussi S; Johansson HJ; Lundberg P; Langel U
J Gene Med; 2006 Oct; 8(10):1262-73. PubMed ID: 16900561
[TBL] [Abstract][Full Text] [Related]
35. Cell-penetrating peptides: mechanism and kinetics of cargo delivery.
Zorko M; Langel U
Adv Drug Deliv Rev; 2005 Feb; 57(4):529-45. PubMed ID: 15722162
[TBL] [Abstract][Full Text] [Related]
36. Membrane interactions of cell-penetrating peptides probed by tryptophan fluorescence and dichroism techniques: correlations of structure to cellular uptake.
Caesar CE; Esbjörner EK; Lincoln P; Nordén B
Biochemistry; 2006 Jun; 45(24):7682-92. PubMed ID: 16768464
[TBL] [Abstract][Full Text] [Related]
37. Cell-penetrating peptides: Nanocarrier for macromolecule delivery in living cells.
Chugh A; Eudes F; Shim YS
IUBMB Life; 2010 Mar; 62(3):183-93. PubMed ID: 20101631
[TBL] [Abstract][Full Text] [Related]
38. Chances and pitfalls of cell penetrating peptides for cellular drug delivery.
Tréhin R; Merkle HP
Eur J Pharm Biopharm; 2004 Sep; 58(2):209-23. PubMed ID: 15296950
[TBL] [Abstract][Full Text] [Related]
39. The cell-penetrating peptide TAT(48-60) induces a non-lamellar phase in DMPC membranes.
Afonin S; Frey A; Bayerl S; Fischer D; Wadhwani P; Weinkauf S; Ulrich AS
Chemphyschem; 2006 Oct; 7(10):2134-42. PubMed ID: 16986196
[TBL] [Abstract][Full Text] [Related]
40. Scavenger receptor-mediated uptake of cell-penetrating peptide nanocomplexes with oligonucleotides.
Ezzat K; Helmfors H; Tudoran O; Juks C; Lindberg S; Padari K; El-Andaloussi S; Pooga M; Langel U
FASEB J; 2012 Mar; 26(3):1172-80. PubMed ID: 22138034
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
